FDA Inspection 1303562 — Soo Aleman, MD

Soo Aleman, MD — FEI 3021335565

The FDA completed an inspection of Soo Aleman, MD on January 20, 2026 in Stockholm. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
January 20, 2026
Fiscal Year
2026
Product Type
Drugs
Project Area
Bioresearch Monitoring
Location
Stockholm (Sweden)